Friedreich ataxia ICD-10 G11.1 · ICD-11 8A03.10

Treatment of Lower Urinary Tract Symptoms and Overactive Bladder in Friedreich Ataxia

People with Friedreich ataxia may develop lower urinary tract symptoms (LUTS), including overactive bladder and urinary storage difficulties. This clinical scenario requires a structured management approach, with treatment options specific to this population.

Clinical Scenario

This protocol addresses individuals with Friedreich ataxia who present with lower urinary tract symptoms — specifically overactive bladder and urinary storage symptoms. Clinical evidence supports consideration of pharmacological therapy in this setting; antimuscarinic medications are among the evaluated options for managing storage symptoms in this population.

Treatment Approach

When pharmacological management is insufficient, an alternative interventional approach targeting the detrusor is among the options considered in the full protocol.

Full selection criteria, options, and clinical pathway are available in the structured protocol below.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1186/s13023-022-02568-3

We conditionally recommend consideration of a trial of antimuscarinic agents in individuals with Friedreich ataxia with LUT symptoms reporting urinary storage symptoms

Antimuscarinic medications may be considered for people with Friedreich ataxia displaying overactive bladder symptoms

Intradetrusor injections of botulinum toxin A or suprapubic catheterization may be considered as alternative intervention

View source ↗